SPHERA FUNDS MANAGEMENT LTD. 13D/13G Filings for Chemomab Therapeutics Ltd. (CMMB)

SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Chemomab Therapeutics Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-08-20
2:36 pm
Purchase
2024-07-2513GChemomab Therapeutics Ltd.
CMMB
SPHERA FUNDS MANAGEMENT LTD.1,214,575
6.560%
1,214,575increase
(New Position)
Filing